Evidence supporting the use of: Saccharomyces boulardii
For the health condition: Inflammatory Bowel Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Saccharomyces boulardii is a probiotic yeast that has been investigated for its potential role in supporting and treating Inflammatory Bowel Disorders (IBD), which include ulcerative colitis and Crohn’s disease. The rationale for its use is primarily grounded in scientific evidence, though the overall strength of the evidence is moderate (rated 3 out of 5).

Several randomized controlled trials and meta-analyses have explored the effectiveness of S. boulardii in IBD. For ulcerative colitis, studies suggest that S. boulardii may help maintain remission when used alongside standard therapies, with some trials showing reduced relapse rates compared to placebo. In Crohn’s disease, results are more mixed; a few small studies have indicated possible benefits in preventing relapse, but larger trials have not consistently shown significant effects.

The proposed mechanisms by which S. boulardii may benefit IBD include modulation of the intestinal microbiome, enhancement of the intestinal barrier, inhibition of pathogenic bacteria, and downregulation of inflammatory responses. S. boulardii has also demonstrated the ability to increase secretory IgA and modulate cytokine production, which could help mitigate the intestinal inflammation characteristic of IBD.

Despite these promising findings, the evidence is not robust enough to recommend S. boulardii as a sole or primary therapy. Most guidelines consider it as a potential adjunctive treatment, particularly in ulcerative colitis, but emphasize the need for more high-quality, large-scale trials. Overall, its use in IBD is scientifically justified but should be considered complementary to standard medical care.

More about saccharomyces boulardii
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

aloe vera
chamomile
dandelion
licorice root
marshmallow
peppermint oil
reishi mushroom
slippery elm bark
spirulina
zinc
turmeric
vitamin D
vitamin C
Acemannan
akkermansia muciniphila
alpha-linolenic acid (ALA)
Andrographolide
Arabinoxylan
2′-Fucosyllactose (2′-FL)
algae
algal oil
alpha-glycosyl isoquercitrin
anthocyanins
Apigenin
Apocynin
Arctiin
Astragalin
Bacillus
bacillus clausii
Bacillus licheniformis
bacillus subtilis
Bacteria
barberry
barley
Basidiomycota
bentonite
Bifidobacterium
Bifidobacterium adolescentis
Bifidobacterium animalis
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
Bioflavonoids
Boswellic Acid
Brassica
anthocyanidins
Avocado
beta caryophyllene
Bifidobacteria
bifidobacterium longum
butyrate triglyceride
butyric acid
cat's claw
citrus pectin
coptis chinesis
curcumin
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactiplantibacillus plantarum
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
luteolin
myrrh
n-acetyl-cysteine (NAC)
n-acetyl-glucosamine
nicotinamide riboside
omega-3 fatty acids
pectin
psyllium
punarnava
rubia cordifolia
saccharomyces boulardii
shiitake mushroom
specialized pro-resolving mediators (SPMs)
streptococcus thermophilus
swertia
tributyrin
Urolithin A
vitamin D3
xylanase
xylooligosaccharides